Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes

BACKGROUND: Hyperglycemia is associated with increased risk of all-site cancer that may be mediated through activation of the renin-angiotensin-system (RAS) and 3-hydroxy-3-methyl-glutaryl-coenzyme-A-reductase (HMGCR) pathways. We examined the joint associations of optimal glycemic control (HbA(1c)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Alice PS, Yang, Xilin, So, Wing-Yee, Luk, Andrea, Ma, Ronald CW, Ozaki, Risa, Cheung, Kitty KT, Lee, Heung-Man, Yu, Linda, Xu, Gang, Chow, Chun-Chung, Chan, Juliana CN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046510/
https://www.ncbi.nlm.nih.gov/pubmed/24886453
http://dx.doi.org/10.1186/1741-7015-12-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046510/
https://www.ncbi.nlm.nih.gov/pubmed/24886453
http://dx.doi.org/10.1186/1741-7015-12-76

Ejemplares similares